
The first trial of creatine in Alzheimer’s disease was just published and the results are big. Patients took 20 grams of creatine monohydrate daily for 8 weeks. Brain creatine levels rose 11%, and cognition significantly improved across multiple domains, including memory, reading, and attention. Nearly every participant stuck with the protocol. No drug, no major side effects. Caveat: it was a small, single-arm pilot study with no placebo group, so results must be interpreted cautiously. Still, encouraging signs from a humble supplement.















